Engaging with biotechnology and pharmaceutical companies is essential to reaching our goal of a cure for all people with cystic fibrosis. These principles and standards for Industry interactions safeguard our independence, objectivity, and ability to make decisions that are in the best interest of people with CF.
Site Search
Showing 31 - 40 of 184 results
13 min read
Press Release
|
|
2 min read
Press Release
|
|
3 min read
Press Release
|
|
6 min read
Press Release
|
|
4 min read
Press Release
|
|
3 min read
Nationwide Effort to Instill Best Practices for Cystic Fibrosis Care is Honored for Excellence
Press Release
|
|
3 min read
Press Release
|
|
3 min read
Revised Law Includes Designated Funding for Rare Diseases
Press Release
|
|
2 min read
Press Release
|
|
3 min read